Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-11-14

Clinical Trial Update: Prospective Analysis of Changes in Background Parenchymal Enhancement (BPE) and Amount of Fibroglandular Tissue on Breast MRI

View source ↗

Summary

Memorial Sloan Kettering Cancer Center's clinical trial evaluating changes in background parenchymal enhancement and fibroglandular tissue on breast MRI has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Status: WITHDRAWN